Nurse-led daily weight tracking to improve heart failure self-care and quality of life
Official title: The Effect of a Nurse-led Daily Weight Monitoring Intervention (Wake and Weigh) on Heart Failure Quality of Life and Self-care
Run by The Cleveland Clinic · NCT07184541 · Data updated 2026-11-12
This pilot will try a simple nurse-led 'Wake and Weigh' weight tracking tool to see if it helps adults 55 and older with heart failure improve self-care and quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years and up |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | The Cleveland Clinic Academic / other |
| Locations | 1 site (Avon, Ohio) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | October 31, 2026 |
| Study ends | December 2026 |
| Registry record updated | September 24, 2025 |
| Trial ID | NCT07184541 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 55 or older who are hospitalized for heart failure, can stand and weigh independently, and have or can obtain a home scale.
✕Probably not a fit
Patients with documented cognitive impairment, a Charlson Comorbidity Index above 4, who cannot stand or weigh independently, or who cannot complete follow-up are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled pilot comparing a nurse-led daily weight monitoring tool called Wake and Weigh with usual care in adults aged 55 and older hospitalized for heart failure. Participants complete the Self-Care in Heart Failure Index and the Kansas City Cardiomyopathy Questionnaire at admission and four weeks after discharge to capture self-care behaviors and symptom-related quality of life. The trial will measure feasibility and intervention fidelity, including how consistently nurses deliver the tool and whether participants use it after discharge. Findings will be used to refine methods for a larger definitive randomized trial.
Why it matters
Potential benefit: If successful, the intervention could help patients detect fluid changes earlier, strengthen daily self-care habits, and potentially reduce symptom burden and hospital readmissions.
How similar studies have gone: Daily weight monitoring and nurse-led self-care support have been tested previously with mixed results—some programs lowered readmissions while others showed limited benefit—so this simplified Wake and Weigh approach is a relatively modest and pragmatic refinement.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults (55 years or older) 2. New or existing diagnosis of HF (regardless of type or length of time since diagnosis). 3. Being treated for HF signs and/or symptoms during the current hospitalization (any of the following: IV diuretic, fluid restriction, low sodium diet). 4. Must be able to read and communicate in English. 5. Must be able to stand and weigh independently. 6. Must have a scale at home, or ability to obtain one for the study. Exclusion Criteria: 1. Documented diagnosis of cognitive impairment. 2. A Charlson Comorbidity Index (CCI) of \>4. This was chosen to exclude patients more likely to have hospital stays longer than a week. A CCI of \>3 was based on research showing a relationship to mortality (Imam et al., 2020), a CCI of ≥ 6 with a 2.8-times higher mortality (Yilmaz \& Omurlu, 2019), and likelihood of longer hospital length of stay for patients with HF if CCI \>2 (Foraker et al., 2014).
Where it's running
-
Cleveland Clinic Avon Hospital
Avon, Ohio, United States Recruiting
Study contacts
- Study coordinator: Lee Anne Siegmund, PhD, RN
- Email: siegmul@ccf.org
- Phone: 216-618-5126
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.